YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Nektar Therapeutics (NASDAQ:NKTR), Quantum-Si Inc (NASDAQ:QSI), and Pacific Biosciences of California Inc (NASDAQ:PACB) are all attracting elevated options activity today, as biotech stocks make volatile moves. NKTR is down 19.1% at $48.97…
Investing.com -- Saudi Arabian stocks fell on Sunday, with losses spreading across Gulf markets after Yemen's Houthis said they attacked targets in Riyadh with missiles and drones, Reuters reported. Still guessing which names to buy? Our A…
Quantum-Si incorporated Q2 2026 Earnings Call Summary - Moby Strategic Roadmap and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1…
Key Points Interested in Quantum-Si Incorporated? Here are five stocks we like better. Proteus launch delayed to Q2 2027: Quantum-Si said it needs an additional instrument-design cycle to improve system repeatability, manufacturing readine…
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.16 per share a year ago. These figures are adjusted for non-recurring ite…
* Quantum-Si press release [https://seekingalpha.com/pr/20619102-quantum-si-reports-second-quarter-2026-financial-results-and-provides-proteus-development] (QSI [https://seekingalpha.com/symbol/QSI]): Q2 GAAP EPS of -$0.11 beats by $0.01.…
Ambiq Micro, Inc. (AMBQ) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.43 per share a year ago. These figures are adjusted for non-recurring items. T…
Stoneridge (SRI) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. This quar…
Quantum-Si Incorporated BRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule de…
BRANFORD, Conn., June 10, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a p…
Multi-City Roadshow is Driving Awareness of Proteus and Developing Customer Funnel for Commercial Launch BRANFORD, Conn., June 03, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a prote…
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. Ha…
[Health Care sector, stock exchange monitor with index information.] Torsten Asmus The semi-annual rebalancing of U.S. equities is officially underway after FTSE Russell unveiled its preliminary list of shifts for the broad-market Russell…
BRANFORD, Conn., May 14, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that…
Quantum-Si logo Key Points Interested in Quantum-Si Incorporated? Here are five stocks we like better. Quantum-Si posted just $258,000 in Q1 2026 revenue and kept its full-year outlook unchanged, signaling that 2026 remains a transition ye…
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.11 per share a year ago. These figures are adjusted for non-recurring item…
Image source: The Motley Fool. Date Thursday, May 7, 2026 at 4:30 p.m. ET Call participants President and Chief Executive Officer — Jeffrey Alan Hawkins Chief Financial Officer — Jeffry R. Keyes Head of Investor Relations — Risa Lindsay Ne…
Successful sequencing on integrated Proteus instruments and continued progress toward amino acid coverage and overall launch capabilities BRANFORD, Conn., May 07, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si,"…
Pitney Bowes (PBI) came out with quarterly earnings of $0.47 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago,…
BRANFORD, Conn., May 01, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that…
BRANFORD, Conn., April 28, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced th…
A few weeks ago, a research paper out of MIT (the college) crossed my desk that most investors would have ignored. It was about worms. Specifically, it was about a team that had successfully mapped the entire brain of a microscopic worm —…
BRANFORD, Conn., April 16, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced…
BRANFORD, Conn., April 15, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced th…
BRANFORD, Conn., April 14, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a…
BRANFORD, Conn., April 10, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced th…
Sequencing Results Utilizing a Proteus Prototype System Exceeds Platinum® Pro BRANFORD, Conn., April 08, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company r…
Multi-city Roadshow To Drive Awareness of Proteus and Develop Customer Funnel for Commercial Launch BRANFORD, Conn., April 06, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomic…
Investors considering a purchase of Quantum-Si Inc (Symbol: QSI) shares, but tentative about paying the going market price of $0.8684/share, might benefit from considering selling puts among the alternative strategies at their disposal. On…
Quantum-Si incorporated Q4 2025 Earnings Call Summary - Moby Strategic Transition and Platform Evolution Management is intentionally transitioning 2026 into a 'market preparation' year, prioritizing the upcoming Proteus launch over maximiz…
Earnings Call Insights: Quantum-Si incorporated (QSI) Q4 2025 MANAGEMENT VIEW * CEO Jeffrey Hawkins indicated that 2026 will be a transition year, with revenue primarily driven by consumable utilization from the installed base and modest n…
Image source: The Motley Fool. DATE Tuesday, March 3, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Jeffrey Hawkins Chief Financial Officer — Jeffry R. Keyes Investor Relations — Risa Lindsay Full Conferenc…
Image source: The Motley Fool. DATE Tuesday, March 3, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Jeffrey HawkinsChief Financial Officer — Jeffry R. KeyesInvestor Relations — Risa Lindsay TAKEAWAYS Quarte…
Quantum-Si logo Key Points Quantum-Si says 2026 will be a “transition year” to prioritize development and commercial readiness for its Proteus platform, targeting a late‑2026 launch with a announced list price of $425,000 and an initial pl…
* Quantum-Si (QSI [https://seekingalpha.com/symbol/QSI]) is scheduled to announce Q4 earnings results on Monday, March 2nd, after market close. * The consensus EPS Estimate is -$0.13 [https://seekingalpha.com/symbol/QSI/earnings/estimates]…
Key Insights Significant control over Quantum-Si by retail investors implies that the general public has more power to influence management and governance-related decisions 44% of the business is held by the top 25 shareholders Recent sale…